Hepion Pharmaceuticals Earnings Estimates, EPS & Revenue | OTC:HEPA

Comments

Hepion Pharmaceuticals Inc Earnings Estimates

HEPAOTCQB

Trade with Public

$0.3180

At close: May 27, 5:00 PM EST

$0.1689

-0.15-46.89%

After Hours: May 12, 7:59 PM EST

Overview NewsEarningsAnalyst Ratings Insider Trades Short Interest

Hepion Pharmaceuticals Earnings Estimates, EPS & Revenue | OTC:HEPA

Hepion Pharmaceuticals (HEPA) is scheduled to report Q4 earnings on March 26, 2026.

Over the last 4 quarters, Hepion Pharmaceuticals has averaged an EPS surprise of 0.39% and a revenue surprise of 0.00%.

Earnings Date

Nov 12

EPS

$-0.040

Quarterly Revenue

$0.00

Annual Revenue

–

Hepion Pharmaceuticals Earnings History

Analyze the earnings history of Hepion Pharmaceuticals using advanced sorting and filters.

Loading calendar...

Hepion Pharmaceuticals (HEPA) Earnings Per Share

The chart below shows Hepion Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q4	2024-04-16	$-121.00	$-131.50	7.98 %
Q3	2023-11-20	$-137.00	$-108.00	-26.9 %
Q1	2023-05-12	$-174.00	$-82.00	-112.2 %
Q4	2023-04-10	$-130.00	$-140.00	7.14 %

Hepion Pharmaceuticals (HEPA) Revenue

The chart below shows Hepion Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Hepion Pharmaceuticals (OTCQB:HEPA) reporting earnings?

Hepion Pharmaceuticals (HEPA) is scheduled to report earnings on March 26, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.

What were the latest earnings per share (EPS) for Hepion Pharmaceuticals (OTCQB:HEPA)?

The Actual EPS was $-0.04, which missed the estimate of $0.00.

What were Hepion Pharmaceuticals’s (OTCQB:HEPA) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

Hepion Pharmaceuticals Earnings Estimates, EPS & Revenue | OTC:HEPA

Hepion Pharmaceuticals (HEPA) is scheduled to report Q4 earnings on March 26, 2026.

Over the last 4 quarters, Hepion Pharmaceuticals has averaged an EPS surprise of 0.39% and a revenue surprise of 0.00%.

Earnings Date

Nov 12

EPS

$-0.040

Quarterly Revenue

$0.00

Annual Revenue

–